Although our patient’s genetic testing results came back as negative, around 40–63% of patients with PUB carry a germline mutation and most commonly the SDHB subunit gene, which requires them to be followed up lifelong because of the increased risk of developing metastatic disease (Withey et al. 2022). The gene discussed is SDHB; the disease is metastatic neoplasm.